The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy-resistant MSS metastatic colorectal cancer (mCRC).

Marwan  Fakih

Honoraria - Amgen

Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Incyte; Mirati Therapeutics; Nouscom; Pfizer; Roche/Genentech; Seagen; Taiho Pharmaceutical

Speakers' Bureau - Guardant Health

Research Funding - Amgen (Inst); Verastem (Inst)

Jaideep Singh  Sandhu

No Relationships to Disclose

Dean  Lim

No Relationships to Disclose

Sierra  Li

No Relationships to Disclose

Chongkai  Wang

No Relationships to Disclose